Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Thyroid nodule update on diagnosis and management.

Tamhane S, Gharib H.

Clin Diabetes Endocrinol. 2016 Oct 3;2:17. doi: 10.1186/s40842-016-0035-7. eCollection 2016. Review.

2.

RETRACTED ARTICLE: Thyroid nodules update in diagnosis and management.

Tamhane S, Gharib H.

Clin Diabetes Endocrinol. 2015 Sep 18;1:11. doi: 10.1186/s40842-015-0011-7. eCollection 2015. Retraction in: Clin Diabetes Endocrinol. 2016 Apr 14;2:10.

3.

Administration of RANKL boosts thymic regeneration upon bone marrow transplantation.

Lopes N, Vachon H, Marie J, Irla M.

EMBO Mol Med. 2017 Jun;9(6):835-851. doi: 10.15252/emmm.201607176.

4.

Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).

Gabriel M, Shaw BE, Brazauskas R, Chen M, Margolis DA, Sengelov H, Dahlberg A, Ahmed IA, Delgado D, Lazarus HM, Gibson B, Myers KC, Kamble RT, Abdel-Mageed A, Li CK, Flowers MED, Battiwalla M, Savani BN, Majhail N, Shaw PJ.

Biol Blood Marrow Transplant. 2017 Aug;23(8):1320-1326. doi: 10.1016/j.bbmt.2017.04.004. Epub 2017 Apr 12.

PMID:
28411175
5.

Late effects of blood and marrow transplantation.

Inamoto Y, Lee SJ.

Haematologica. 2017 Apr;102(4):614-625. doi: 10.3324/haematol.2016.150250. Epub 2017 Feb 23. Review.

6.

Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update.

Guida M, Castaldi MA, Rosamilio R, Giudice V, Orio F, Selleri C.

J Ovarian Res. 2016 Nov 1;9(1):72. Review.

7.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Morton LM, Saber W, Baker KS, Barrett AJ, Bhatia S, Engels EA, Gadalla SM, Kleiner DE, Pavletic S, Burns LJ.

Biol Blood Marrow Transplant. 2017 Mar;23(3):367-378. doi: 10.1016/j.bbmt.2016.09.005. Epub 2016 Sep 12.

PMID:
27634019
8.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.

Shaw BE, Hahn T, Martin PJ, Mitchell SA, Petersdorf EW, Armstrong GT, Shelburne N, Storer BE, Bhatia S.

Biol Blood Marrow Transplant. 2017 Jan;23(1):10-23. doi: 10.1016/j.bbmt.2016.08.018. Epub 2016 Aug 30. Review.

9.

Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review.

Villarreal CD, Alanis JC, Pérez JC, Candiani JO.

An Bras Dermatol. 2016 May-Jun;91(3):336-43. doi: 10.1590/abd1806-4841.20164180. Review.

10.

Glioblastoma Multiforme in a Post Allogeneic Stem Cell Transplant Patient. A Case Report and Literature Review of Post Transplant Neurological Tumors.

Ganapule AP, Varghese SS, Chacko G, Aparna I, Viswabandya A.

Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):192-5. doi: 10.1007/s12288-015-0500-y. Epub 2015 Jan 14.

11.

Management of oral Graft versus Host Disease with topical agents: A systematic review.

Albuquerque R, Khan Z, Poveda A, Higham J, Richards A, Monteiro L, Jané-Salas E, Lopez-Lopez J, Warnakulasuriya S.

Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21(1):e72-81. Review.

12.

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L.

Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020. Review.

13.

Survival of patients who develop solid tumors following hematopoietic stem cell transplantation.

Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE.

Bone Marrow Transplant. 2016 Jan;51(1):83-8. doi: 10.1038/bmt.2015.203. Epub 2015 Sep 14.

14.

Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients.

Hobbs GS, Perales MA.

J Clin Med. 2015 Mar 19;4(3):488-503. doi: 10.3390/jcm4030488. Review.

15.

Oral squamous cell carcinoma arising in a patient after hematopoietic stem cell transplantation with bisphosphonate-related osteonecrosis of the jaws.

Arduino PG, Scully C, Chiusa L, Broccoletti R.

Case Rep Dent. 2015;2015:831418. doi: 10.1155/2015/831418. Epub 2015 Apr 20.

16.

Prognostic understanding, quality of life and mood in patients undergoing hematopoietic stem cell transplantation.

El-Jawahri A, Traeger L, Kuzmuk K, Eusebio J, Vandusen H, Keenan T, Shin J, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Ballen KK, Spitzer TR, Graubert TA, McAfee S, Dey B, Chen YB, Temel JS.

Bone Marrow Transplant. 2015 Aug;50(8):1119-24. doi: 10.1038/bmt.2015.113. Epub 2015 May 11.

17.

Secondary solid cancer screening following hematopoietic cell transplantation.

Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, Bitan M, DeFilipp Z, Gregory TK, Greinix HT, Hamadani M, Hamilton BK, Hayashi RJ, Jacobsohn DA, Kamble RT, Kasow KA, Khera N, Lazarus HM, Malone AK, Lupo-Stanghellini MT, Margossian SP, Muffly LS, Norkin M, Ramanathan M, Salooja N, Schoemans H, Wingard JR, Wirk B, Wood WA, Yong A, Duncan CN, Flowers ME, Majhail NS.

Bone Marrow Transplant. 2015 Aug;50(8):1013-23. doi: 10.1038/bmt.2015.63. Epub 2015 Mar 30. Review.

18.

Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant.

Cecchini M, Sznol M, Seropian S.

J Immunother Cancer. 2015 Mar 24;3:10. doi: 10.1186/s40425-015-0054-4. eCollection 2015.

19.

Interleukin-22: immunobiology and pathology.

Dudakov JA, Hanash AM, van den Brink MR.

Annu Rev Immunol. 2015;33:747-85. doi: 10.1146/annurev-immunol-032414-112123. Epub 2015 Feb 11. Review.

20.

Combinations of immunotherapy and radiation in cancer therapy.

Vatner RE, Cooper BT, Vanpouille-Box C, Demaria S, Formenti SC.

Front Oncol. 2014 Nov 28;4:325. doi: 10.3389/fonc.2014.00325. eCollection 2014. Review.

Supplemental Content

Support Center